Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Endocrinology
•
Adrenal Disorders
Would you recommend testing for adrenal dysfunction in a euvolemic and hypertensive patient on anti-hypertensive therapy presenting with combined hyperkalemia and hyponatremia?
Related Questions
Do patients with central adrenal insufficiency on maintenance hydrocortisone therapy require doubling of their corticosteroid during chemotherapy cycles?
Can 24-hour urine aldosterone levels be used to screen for primary aldosteronism in a patient taking finerenone?
Do you recommend combined baseline cortisol and DHEA-S testing to improve the efficiency and accuracy of adrenal insufficiency diagnosis?
Does Entresto interfere with the measurement of ARR (Aldosterone to Renin Ratio) when working up a patient for hyperaldosteronism?
Do progesterone only oral contraceptive pills affect cortisol binding globulin?
What 60 minute cortisol threshold value do you use for diagnosis of adrenal insufficiency after ACTH stimulation?
Would elevated bone mineral density/T-score be enough to make a diagnosis of osteopetrosis?
How do you approach treatment of a patient with bilateral adrenal gland thickening & biochemical evidence of ACTH-independent hypercortisolism?
Should we aim to reduce or stop thiazides in patients with thiazide-induced hypercalcemia given its similar risk profile to untreated primary hyperparathyroidism?
Should GLP-1 agonists be held during chemotherapy?
